ARTICLE | Distillery Therapeutics
Therapeutics: CD93 (C1QR)
October 22, 2015 7:00 AM UTC
Mouse and cell studies suggest inhibiting CD93 could help treat mixed-lineage leukemia (MLL)-rearranged acute myeloid leukemia (AML). Human MLL-rearranged AML cells had higher levels of CD93 than non-...